recent post

Medicover Hospitals, Navi Mumbai collaborates with Senegal, West Africa 

September 17, 2024
recent post

Redcliffe Labs secures $42 million in a Series C funding

recent post

Laurus Labs opens R&D centre in Hyderabad’s Genome Valley

recent post

Ruby Hall Clinic installs CT Scan Machine in Hinjewadi, Pune

recent post

IIIT Hyderabad launches online course on AI for medical professionals

imt Logo cross btn

Lupin completes acquisition of two brands from Sanofi in Europe and Canada

Lupin completes acquisition of two brands from Sanofi in Europe and Canada

The transaction aligns with Lupin's strategy to grow its global presence in specialty areas Lupin announced that its European hub entity, Lupin Atlantis Holdings, has completed the acquisition of two well-known brands, Aarane in Germany and Nalcrom in Canada and the Netherlands, along with the associated trademark rights, from Sanofi. The transaction aligns with Lupin's strategy to grow its global presence in speciality areas, where the company has a leading position, with high-quality products that are innovative or unique in the market. This acquisition will enhance Lupin's Respiratory business in Germany, by aiding in the expansion of the newly established franchise, following the introduction of Luforbec.